Frontier IP Group (FIPP) 68.50p £28.85m Frontier IP, a specialist in commercialising university intellectual property, noted the following announcement from portfolio company Exscientia, a world leader in artificial intelligence ("AI") drug discovery, that it has entered into a drug discovery collaboration with Rallybio. Rallybio is a US-based drug development company aiming to transform the lives of patients with rare diseases. Exscientia's other partnerships include collaborations with Celgene, GSK, Roche, Sanofi, GT Apeiron and Evotec. Frontier IP currently holds a 3.25% stake in the Company.
Frontier IP Group Plc (FIPP.L) Announced that portfolio company Exscientia ("Exscientia" or the "Company"), a world leader in artificial intelligence ("AI") drug discovery, has entered into a drug discovery collaboration with Rallybio. Rallybio is a US-based drug development company aiming to transform the lives of patients with rare diseases.
RNS Number: 6261 G Frontier IP Group plc 25 July 2019 RNS Reach. Portfolio news- Exscientia enters broad rare disease drug discovery collaboration with Rallybio. Exscientia, a world-leading Artificial Intelligence- driven drug discovery company, announced today that it has entered into a collaboration with Rallybio, a U.S.- based drug development company,...
RNS Number: 5571 F Frontier IP Group plc 15 July 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Frontier IP (FIPP.L) 78.75p £33.1m Frontier IP, a specialist in commercialising university intellectual property, noted the following announcement from portfolio company Exscientia, a world leader in AI drug discovery, that it has entered into a drug-discovery partnership with GT Apeiron Therapeutics. GT Apeiron is a Shanghai-headquartered biotechnology drug-discovery platform launched with $27m backing from GT Healthcare Capital Partners, a life sciences-focused private equity partnership. GT Healthcare is also an investor in Exscientia. As part of the agreement, Exscientia is entitled to become a shareholder in GT Apeiron as well as receiving milestones and royalties based on the clinical and commercial success of each programme. GT Healthcare invested in Exscientia as part of a Series B financing round, which raised $26m to scale up the Company's pipeline and advance selected programmes towards clinical development. Further details were announced by Frontier IP on 7 Jan 2019. Exscientia's existing partnerships include collaborations with Celgene, GSK, Roche, Sanofi and Evotec. Frontier IP holds a 3.32% stake in the Company.
Frontier IP Group Plc (FIPP.L) Announced that its portfolio company Exscientia (Exscientia), a world leader in artificial intelligence (AI) drug discovery, has entered into a drug-discovery partnership with GT Apeiron Therapeutics (GT Apeiron). GT Apeiron is a Shanghai-headquartered biotechnology drug-discovery platform launched with $27 million backing from GT Healthcare Capital Partners (GT Healthcare), a life sciences-focused private equity partnership. GT Healthcare is also an investor in Exscientia. As part of the agreement, Exscientia is entitled to become a shareholder in GT Apeiron as well as receiving milestones and royalties based on the clinical and commercial success of each programme
RNS Number: 1681 C Frontier IP Group plc 14 June 2019 RNS Reach. GT Apeiron is a Shanghai- headquartered biotechnology drug-discovery platform launched with US $27 million backing from GT Healthcare Capital Partners, a life sciences-focused private equity partnership. GT Healthcare invested in Exscientia as part of a Series B financing round, which raised US...
RNS Number: 7460 A Frontier IP Group plc 31 May 2019 31 May 2019. Frontier IP, which specialises in commercialising university intellectual property, announces that the Company's issued share capital as at the date of this announcement comprises 42,431,372 ordinary shares, with one voting right per share. The Company does not hold any ordinary shares in...
RNS Number: 8104 A Frontier IP Group plc 31 May 2019 31 May 2019. Frontier IP, a specialist in commercialising university intellectual property, announces that David Cairns has notified the Group of his decision to step down from the Board. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Frontier IP Group Plc (FIPP.L) Announced that portfolio company Fieldwork Robotics (the Company or Fieldwork) has completed initial field trials of its robot raspberry harvesting system. It holds 27.5 per cent of the company. Data from the trials will be used to refine and improve the prototype system before further field trials are held later this year. If the trials are successful, then manufacturing of a commercial system is expected to begin in 2020. The trials were held in West Sussex at a farm owned by Fieldwork's industry partner, leading UK soft-fruit grower Hall Hunter Partnership (Hall Hunter). Hall Hunter supplies Marks & Spencer, Tesco and Waitrose. The move follows University of Plymouth spin out Fieldwork being awarded a £547,250 Innovate UK grant earlier this year towards a £671,484 project to develop a multiarmed robot prototype. Other partners include the University of Plymouth and the National Physical Laboratory.
The trials were held in West Sussex at a farm owned by Fieldwork's industry partner, leading UK soft-fruit grower Hall Hunter Partnership. The move follows University of Plymouth spin out Fieldwork being awarded a £547,250 Innovate UK grant earlier this year towards a £671,484 project to develop a multi-armed robot prototype. Other partners include the...
RNS Number: 0324 Z Frontier IP Group plc 15 May 2019 15 May 2019. Exercise of options by a director. Frontier IP, a specialist in commercialising university intellectual property, announces that David Cairns has, on 14 May 2019, exercised options over a total of 325,000 ordinary shares of 10 pence each in the capital of the Company.
RNS Number: 0324 Z Frontier IP Group plc 15 May 2019 15 May 2019. Exercise of options by a director. Frontier IP, a specialist in commercialising university intellectual property, announces that David Cairns has, on 14 May 2019, exercised options over a total of 325,000 ordinary shares of 10 pence each in the capital of the Company.
RNS Number: 6937 Y Frontier IP Group plc 10 May 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
It brings together 14 partners from Portugal, Ireland, France, Spain and the United Kingdom, and is being coordinated by one of Frontier IP's partner universities in Portugal, NOVA University Lisbon, NOVA School of Science and Technology. Emporia4KT is backed by approximately €2.2 million funding from the European Union's INTERREG Atlantic Area European...
It brings together 14 partners from Portugal, Ireland, France, Spain and the United Kingdom, and is being coordinated by one of Frontier IP's partner universities in Portugal, NOVA University Lisbon, NOVA School of Science and Technology. Emporia4KT is backed by approximately €2.2 million funding from the European Union's INTERREG Atlantic Area European...
Frontier IP Group Plc (FIPP.L) Announced that Parkside Architectural Tiles (Parkside), the commercial arm of Topps Tiles plc serving the architecture and design market, is to launch an exclusive range of sustainable tiles made by the Group's portfolio company Alusid (Alusid or the Company). The company holds a 35.6% stake in the company. Separately, the company announced that it is hosting an event jointly with the Royal Academy of Engineering (the Academy) on the evening of 08 April 2019. Separately, the company announced that Robert Bosch Limited (Bosch UK) has entered into an agreement to work with portfolio company Pulsiv Solar (Pulsiv or the Company) to optimise the design of the company's energy-efficient solar micro-inverter prototype. The company holds an 18.9% stake in Pulsiv.
Portfolio news- Bosch UK to work with Pulsiv Solar to optimise energy efficient solar power technology. When the prototype moves into full-scale production University of Plymouth spin-out Pulsiv will be able to market the devices as "Engineered by Bosch." Bosch UK is a subsidiary of Robert Bosch GmbH, a leading global supplier of technology and services that...
RNS Number: 3589 V Frontier IP Group plc 08 April 2019 8 April 2019. Frontier IP investor event at the Royal Academy of Engineering, London, 8 April 2019. The event is being held at the Royal Academy of Engineering's headquarters in London.
RNS Number: 3591 V Frontier IP Group plc 08 April 2019 8 April 2019. They will be launched at this year's Clerkenwell Design Week in London, from the 21 to 23 May.. Alusid, a spin out from the University of Central Lancashire, has already enjoyed success with its SilicaStone-branded tiles, tabletops and other surfaces.
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    42.11M
Watchlist